# Trending Content OS — Daily Run
**Run date:** 2026-10-08

---

## 1. Preflight Summary

```yaml
preflight_status:
  all_sections_present: true
  missing_sections: []
  site_niche_set: true
  target_audience_set: true
  site_url_set: false
  serpapi_connected: true
  google_trends_available: true
  google_trends_tool: "serpapi_prefetch"
  active_tools: [serpapi_news, serpapi_trends_prefetch, google_news_radar]
  inactive_tools: [reddit_direct, exa_search, rss_direct_fetch]
  can_run_signal_listener: true
  notes: "site_url not configured — self-check skipped; competitor-list fallback (configs/competitor_list.yaml) used for duplicate/SERP-gap context. Recent Coverage list (last 7 days) used as primary dedup source per user instruction. No deferred_topics.yaml entries had a recheck_on date due today. Run-history recurring-theme check: ARPA-H SURPASS program has now appeared in 3 runs (10/01, 10/07, 10/08 radar) — flagged stale/recurring below."
```

---

## 2. Google News Radar — Coverage Summary

Clusters identified across the 12-query, 144-headline radar pull:

| Cluster | Main storyline | Disposition |
|---|---|---|
| **FDA recalls** | Gatorade (dyes), Salata salad dressing (Salmonella), blood pressure meds — all previously covered; **[eye drop recall, millions of bottles](https://www.prevention.com/health/a74079654/fda-updates-eye-drop-recall/)** is new | Gatorade/Salata/BP meds → **existing/rejected**. Eye drop recall → **RETAINED (P1)** |
| **Clinical trials (consumer-relevant)** | **[T1D patients off insulin in early trial](https://www.nbcnews.com/health/health-news/early-clinical-trial-people-type-1-diabetes-are-able-go-insulin-rcna601171)** (new); **[UC Davis AI medication device for memory loss](https://health.ucdavis.edu/news/headlines/clinical-trial-tests-ai-assisted-medication-device-for-older-adults-with-memory-loss/2026/09)** (new); sauna/heat depression trial — already covered | Two new trials **RETAINED**; sauna story **rejected (existing)** |
| **Clinical trials (B2B/infrastructure)** | Ochsner AI screening, Pfizer AI matching, Mount Sinai EHR-to-EDC, Verana/Bitfount, Rovia, IceCure expansion, UNC Rett gene therapy, UNLV women's health trials, NeuWire stroke device | **Rejected** — trade-press/B2B framing or too niche for a general health audience |
| **Medical research digests** | **[News-Medical: microglia protective role in Parkinson's](https://www.news-medical.net/news/20261007/Study-uncovers-a-protective-role-for-microglia-in-Parkinsons-disease.aspx)** (new); Nobel/optogenetics explainer (existing); Harvard viral-infection cell study, Nature ALS Finland study, UNMC/Susquehanna digests, UCLA "Neural Consult" app | Microglia study **RETAINED (P2)**; rest **rejected** (existing or too niche/academic-digest, weak audience pull) |
| **Influencer/trust-in-health-content** | Pew "what do health influencers post about" (existing); **[VCU: TikTok docs' influence on Gen Z](https://news.vcu.edu/article/popular-tiktok-docs-have-big-influence-on-gen-z-followers-new-vcu-research-finds)** (new angle) | Pew piece **existing/rejected**; VCU study **RETAINED as UPDATE (P3)** |
| **Health insurance/policy** | Medicare-for-all polling, HHS price-transparency rule, ACA $500 "stunt," federal premium hikes, Vance insurer fraud crackdown, Wisconsin governor race | **Rejected — off-category** (pure political/insurance-business, excluded per category_rules) |
| **Wellness lifestyle/local/commerce** | Menopause wellness binge, DC wellness resort, Rochester "wellness dog," Shrewsbury/Purdue/CU Denver events, Army coaching, Amazon Prime Day wellness deals, Forbes "$6.8T wellness boom," Gilead×Calm partnership | **Rejected — off-category** (local/promotional/commerce/business-trend, no evidence angle) |
| **Celebrity mental health chatter** | Stephen A. Smith, Lane Johnson mental health comments (Trends rising queries) | **Rejected** — celebrity-adjacent, no clear evidence angle |
| **WHO global health estimates** | New WHO global health landscape data release | **Monitor (P5)** — legitimate public-health data release but global/aggregate scope, weak direct US-audience angle without a sharper hook |
| **Benefits/insurance-shopping search terms** | Costco/Meritain/Devoted/UHC portal, open enrollment 2027, SNAP rule changes | **Rejected — off-category** (benefits/policy shopping content, not health/wellness editorial) |
| **GLP-1/weight-loss pipeline (Trends-only)** | Six-month tirzepatide data, CBL-514 injection, diet soda vs. water | **Deferred/monitor** — real search interest but no corroborating news article in today's radar; existing coverage (10/04) already owns "what's next" angle. Added to deferred_topics for recheck in 3 days. |

---

## 3. Signal Summary

```yaml
signal_summary:
  run_started_at: "2026-10-08T06:00:00Z"
  run_completed_at: "2026-10-08T06:45:00Z"
  total_signals_reviewed: 153
  total_signals_retained: 5
  total_rejected: 148
  google_trends_available: true
  search_velocity_source: "google_trends"
  rejection_breakdown:
    off_category: 62
    brand_safety: 2
    duplicate: 14
    weak_signal: 60
    unverified_claim: 0
    other: 10
  highest_priority_topic: "FDA recalls millions of bottles of eye drops nationwide"
  strongest_signal_source: "Prevention / NBC News"
  tools_unavailable: [reddit_direct_json, exa_search, direct_rss_fetch]
  notes: "Google News Radar + Trends pre-fetch used as primary input (no direct Reddit/Exa this run). ARPA-H SURPASS program recurring across 3 consecutive run dates — flagged stale, suppressed again today. Gatorade/Salata/blood-pressure recalls, Nobel/optogenetics, sauna-depression trial, World Mental Health Day, and Pew influencer piece all confirmed as existing coverage per Recent Coverage list — no material new development found to justify an update."
```

---

## 4. Skill 02b — Health Claim Verification Gate: Routing Summary

| Candidate | Risk type | Primary source | Claim alignment | Result |
|---|---|---|---|---|
| Eye drop recall | recall | FDA notice (referenced in Prevention headline) | matches | **Pass** — confidence capped Medium (single outlet captured today; confirm FDA.gov enforcement report before publish) |
| T1D off-insulin trial | clinical_trial | trusted_secondary (NBC names trial/institution) | mild_overstatement | **Pass** — note required: early-phase/small-cohort, avoid implying cure |
| Microglia/Parkinson's study | medical_study | journal (News-Medical names publication) | matches | **Pass** — flag likely preclinical/animal-model finding, qualify before generalizing to humans |
| UC Davis AI medication device trial | clinical_trial | trusted_secondary (UC Davis Health official newsroom) | matches | **Pass** |
| VCU TikTok-docs study | not applicable (media/social-science research, no treatment/dosage claim) | n/a | n/a | **Not triggered** — proceeds without gate |

No candidate was rejected or routed to Monitor at this gate.

---

## 5. Final Editorial Priority Board

| Priority | Topic | Trend | Opp. | Discover | Urgency | Confidence | Status | Sources |
|---|---|---|---|---|---|---|---|---|
| **P1** | FDA recalls millions of bottles of eye drops nationwide | 72 | 78 | 4 | now | medium | new | [Prevention](https://www.prevention.com/health/a74079654/fda-updates-eye-drop-recall/) |
| **P1** | Early trial: Type 1 diabetes patients able to go off insulin | 75 | 80 | 5 | today | medium | new | [NBC News](https://www.nbcnews.com/health/health-news/early-clinical-trial-people-type-1-diabetes-are-able-go-insulin-rcna601171) |
| **P2** | Study finds microglia play protective role in Parkinson's | 58 | 68 | 3 | this_week | medium | new | [News-Medical](https://www.news-medical.net/news/20261007/Study-uncovers-a-protective-role-for-microglia-in-Parkinsons-disease.aspx) |
| **P3** | VCU: TikTok doctors' outsized influence on Gen Z health views | 60 | 58 | 3 | this_week | medium | update | [VCU News](https://news.vcu.edu/article/popular-tiktok-docs-have-big-influence-on-gen-z-followers-new-vcu-research-finds), [Pew](https://www.pewresearch.org/data-labs/2026/10/07/what-do-health-and-wellness-influencers-post-about/) |
| **P3** | AI-assisted medication device trial for older adults with memory loss | 55 | 65 | 3 | this_week | medium | new | [UC Davis Health](https://health.ucdavis.edu/news/headlines/clinical-trial-tests-ai-assisted-medication-device-for-older-adults-with-memory-loss/2026/09) |

```yaml
summary:
  total_topics: 5
  high_priority_count: 2
  immediate_actions: "Publish eye-drop recall and T1D insulin-trial briefs today; confirm FDA.gov enforcement notice and NBC's named trial source before filing."
pass_to_next_layer: false
```

---

## 6. Editorial Briefs

### P1 — FDA Recalls Millions of Bottles of Eye Drops Nationwide

```yaml
brief:
  primary_headline: "FDA Recalls Millions of Eye Drop Bottles Nationwide — What to Check Before You Use Yours"
  alternate_headlines:
    - "Eye Drop Recall 2026: Full List of Affected Brands and Lot Numbers"
    - "Why the FDA Just Pulled Millions of Eye Drop Bottles From Shelves"
  topic: "FDA eye drop recall, millions of bottles, nationwide"
  primary_entity: "FDA eye drop recall"
  search_intent: "informational + practical (what to check / what to do)"
  angle: "Service-journalism safety explainer: what's affected, why, and what consumers should do with bottles they already own — framed against the pattern of a very active 2026 recall year (Gatorade, Salata, BP meds)."
  why_now: "Breaking same-day (10/08) FDA notice covering millions of units — not previously covered; distinct from this week's Gatorade/Salata/BP-medication recalls."
  integrity_flags:
    - "⚠️ Integrity note: Confirm exact FDA enforcement report number/lot codes directly via FDA.gov before publishing — only one secondary outlet captured in today's signal set."
  outline:
    intro: "What happened and how many bottles/brands are affected"
    sections: ["Why the recall was issued (contamination/sterility/other)", "Which brands/lot numbers are affected", "Health risks if already used", "What to do with affected bottles", "How this fits 2026's recall pattern"]
    conclusion: "Where to check lot numbers and report adverse effects"
  key_data_points: ["Millions of bottles nationwide (exact count TBD — source FDA.gov)", "Pattern: multiple major FDA recalls in Oct 2026 alone"]
  source_plan:
    - { publisher: "Prevention", url: "https://www.prevention.com/health/a74079654/fda-updates-eye-drop-recall/", tier: 2, used_for: "Initial recall report" }
    - { publisher: "FDA.gov Enforcement Reports", url: "[URL unverified — confirm before publish]", tier: 1, used_for: "Primary recall notice, lot numbers" }
  evidence_requirements: "Moderate — recall details, lot numbers, FDA contamination findings"
  expert_sources:
    - { type: "Ophthalmologist or FDA spokesperson", reason: "Confirm health risk of contaminated/non-sterile eye drops" }
  internal_links: ["Prior FDA recall coverage (Gatorade, Salata, BP meds) — cluster page"]
  visual_brief: "Product/lot-number callout graphic; avoid generic stock eye imagery"
  seo:
    primary_keyword: "eye drop recall 2026"
    supporting_keywords: ["FDA eye drop recall brands", "eye drop recall lot numbers", "is my eye drop recalled"]
    format: "News explainer + checklist"
    schema_markup: "NewsArticle"
    cluster: "FDA recalls 2026"
  discover_notes: "Specific entity + natural 'is my product recalled' query + primary FDA source available = strong AI-citation candidate once FDA notice is confirmed."
  key_takeaways: ["Check lot numbers against FDA list", "Stop use if affected", "Report adverse reactions to FDA MedWatch"]
  estimated_word_count: "600–800"
execution_notes: "Confirm FDA.gov primary notice before publish per 02b medium-confidence cap."
confidence: medium
pass_to_next_layer: true
```

### P1 — Early Clinical Trial: Type 1 Diabetes Patients Able to Go Off Insulin

```yaml
brief:
  primary_headline: "In Early Trial, People With Type 1 Diabetes Went Off Insulin — Here's What That Actually Means"
  alternate_headlines:
    - "Type 1 Diabetes Breakthrough? What the New Insulin-Free Trial Really Shows"
    - "Is a Cure for Type 1 Diabetes Closer? Inside the Latest Clinical Trial"
  topic: "Early clinical trial — Type 1 diabetes patients able to go off insulin"
  primary_entity: "Type 1 diabetes insulin-independence trial"
  search_intent: "informational + skeptical ('is this really a cure')"
  angle: "Measured explainer that separates the real finding (early-phase, small cohort) from the headline implication of a cure — what's proven, what's not, and who it could eventually help."
  why_now: "New NBC News report (10/04) on an early clinical trial result, not previously covered; T1D audience has high evidence-seeking interest."
  integrity_flags:
    - "⚠️ Integrity note: Early-phase/small-cohort result — do not frame as a cure. Clarify study phase, sample size, and follow-up duration once primary source is confirmed."
  outline:
    intro: "What the trial found"
    sections: ["What the treatment/approach actually is", "Trial phase, sample size, follow-up length", "What 'off insulin' does and doesn't mean clinically", "Expert caution on early-phase data", "What's next (larger trials, timeline to approval)"]
    conclusion: "Bottom line for people living with T1D today"
  key_data_points: ["Early-phase trial results (exact n and duration — confirm from primary source)"]
  source_plan:
    - { publisher: "NBC News", url: "https://www.nbcnews.com/health/health-news/early-clinical-trial-people-type-1-diabetes-are-able-go-insulin-rcna601171", tier: 2, used_for: "Primary trial report" }
  evidence_requirements: "Heavy — chronic disease / treatment claim requires peer-reviewed or named-trial sourcing, observational-vs-trial distinction"
  expert_sources:
    - { type: "Endocrinologist, not affiliated with the trial", reason: "Independent context on significance and limitations" }
  internal_links: ["Chronic disease management cluster", "GLP-1/metabolic disease coverage"]
  visual_brief: "Clear diagram of mechanism if available; avoid triumphant 'cured' framing imagery"
  seo:
    primary_keyword: "type 1 diabetes insulin free trial"
    supporting_keywords: ["type 1 diabetes cure 2026", "new type 1 diabetes treatment trial"]
    format: "News explainer"
    schema_markup: "NewsArticle"
    cluster: "Chronic disease management"
  discover_notes: "High AI-citation potential — specific named trial, natural question format ('can type 1 diabetes be cured'), durable topic."
  key_takeaways: ["Early-phase result, not an approved treatment", "Small cohort — not yet generalizable", "Larger trials needed before clinical use"]
  estimated_word_count: "700–900"
execution_notes: "Confirm trial name/phase/institution directly; do not rely on headline framing alone."
confidence: medium
pass_to_next_layer: true
```

### P2 — Study Finds Microglia Play Protective Role in Parkinson's

```yaml
brief:
  primary_headline: "Scientists Find a Surprising Protective Role for Brain Cells in Parkinson's Disease"
  alternate_headlines:
    - "This Brain Cell Type May Actually Help Fight Parkinson's — New Study"
    - "Microglia Aren't Just the Villain in Parkinson's, Study Suggests"
  topic: "Microglia protective role in Parkinson's disease — new study"
  primary_entity: "Microglia / Parkinson's disease research"
  search_intent: "informational"
  angle: "Explain what the finding actually shows (likely preclinical), why it complicates the standard 'inflammation is bad' Parkinson's narrative, and what it means for future treatment research."
  why_now: "New study coverage (10/07), no prior coverage of this specific finding."
  integrity_flags:
    - "⚠️ Integrity note: Confirm whether finding is from an animal/preclinical model or human tissue/data — do not generalize to patient treatment implications without qualification."
  outline:
    intro: "The surprising finding"
    sections: ["What microglia normally do in the brain", "What this study found", "Study type/model (confirm before publishing)", "What it means for future Parkinson's treatment", "Expert caution on translating to humans"]
    conclusion: "What's next in this research line"
  key_data_points: ["Study finding on microglia's protective function — confirm journal, model type, and sample size from primary source"]
  source_plan:
    - { publisher: "News-Medical", url: "https://www.news-medical.net/news/20261007/Study-uncovers-a-protective-role-for-microglia-in-Parkinsons-disease.aspx", tier: 2, used_for: "Primary coverage of study" }
  evidence_requirements: "Heavy — neuroscience/disease mechanism claim, must name journal and clarify model type"
  expert_sources:
    - { type: "Neurologist or Parkinson's researcher", reason: "Context on significance vs. existing inflammation research" }
  internal_links: ["Chronic disease management cluster", "Aging and longevity cluster"]
  visual_brief: "Simple brain-cell diagram; avoid alarmist 'brain disease' stock imagery"
  seo:
    primary_keyword: "microglia Parkinson's disease study"
    supporting_keywords: ["Parkinson's new research 2026", "brain inflammation Parkinson's"]
    format: "Research explainer"
    schema_markup: "NewsArticle"
    cluster: "Chronic disease management / neuroscience"
  discover_notes: "Moderate citation potential — specific finding, but likely preclinical, which caps durability of practical takeaway."
  key_takeaways: ["Finding complicates simple 'inflammation=bad' Parkinson's model", "Clarify model type before drawing patient-relevant conclusions"]
  estimated_word_count: "600–750"
execution_notes: "Verify journal/DOI and model type (animal vs. human) before publishing."
confidence: medium
pass_to_next_layer: true
```

### P3 — VCU: TikTok Doctors' Influence on Gen Z Health Views (Concise)

```yaml
brief:
  headline: "TikTok Doctors Are Shaping How Gen Z Thinks About Health — New Research Shows How Much"
  topic: "VCU study on TikTok doctor influence on Gen Z, update to Pew influencer research"
  angle: "Pairs new VCU academic findings with the Pew influencer-content study from this week to assess whether young audiences can tell credible medical creators from unqualified ones."
  key_data_points: ["VCU research on TikTok doctor influence on Gen Z followers", "Pew: most health-influencer medical content comes from credentialed healthcare professionals"]
  integrity_flags: ["⚠️ Integrity note: distinguish correlation (watching → trusting) from causation (watching → behavior change) in VCU findings"]
  expert_type_needed: "Health communication researcher or social media/public health academic"
  seo:
    primary_keyword: "TikTok doctors Gen Z health"
    format: "Trend explainer"
    serp_difficulty: "Medium"
  sources:
    - { publisher: "VCU News", url: "https://news.vcu.edu/article/popular-tiktok-docs-have-big-influence-on-gen-z-followers-new-vcu-research-finds" }
    - { publisher: "Pew Research Center", url: "https://www.pewresearch.org/data-labs/2026/10/07/what-do-health-and-wellness-influencers-post-about/" }
  estimated_word_count: "500–650"
```

### P3 — AI-Assisted Medication Device Trial for Memory Loss (Concise)

```yaml
brief:
  headline: "New Clinical Trial Tests an AI Device to Help Older Adults Remember Their Medications"
  topic: "UC Davis clinical trial — AI-assisted medication device for older adults with memory loss"
  angle: "Practical look at a tech-forward solution to medication non-adherence in dementia/memory-loss caregiving — what the device does and what the trial will measure."
  key_data_points: ["UC Davis Health trial testing AI-assisted medication device for older adults with memory loss"]
  integrity_flags: ["⚠️ Integrity note: trial-stage device — not yet FDA-cleared or commercially available; avoid implying it's ready for home use"]
  expert_type_needed: "Geriatrician or caregiving/adherence researcher"
  seo:
    primary_keyword: "AI medication device memory loss trial"
    format: "Trial explainer"
    serp_difficulty: "Easy"
  sources:
    - { publisher: "UC Davis Health", url: "https://health.ucdavis.edu/news/headlines/clinical-trial-tests-ai-assisted-medication-device-for-older-adults-with-memory-loss/2026/09" }
  estimated_word_count: "450–600"
```

---

## 7. Rejected Topics Log

| Topic | Reason |
|---|---|
| Gatorade recall (122K cases, 37 states) | `duplicate` — covered 10/06, no new development |
| Salata salad dressing recall | `duplicate` — covered 10/04 |
| Blood pressure medication recall | `duplicate` — covered 10/07; bottle-count variance is not a new development |
| ARPA-H SURPASS program (Fierce Biotech, Medical Daily) | `duplicate` — 3rd consecutive appearance (10/01, 10/07, 10/08); flagged recurring/stale |
| World Mental Health Day 2026 | `duplicate` — covered 10/07, no new angle beyond approaching date |
| Pew health/wellness influencer study | `duplicate` — covered 10/07 (spun into VCU update candidate instead) |
| Nobel Prize / optogenetics (Stanford explainer, PBS) | `duplicate` — covered 10/06 |
| NPR sauna/heat therapy for depression | `duplicate` — covered 10/06 |
| Medicare-for-all polling, HHS price-transparency rule, ACA $500 stunt, federal premium hikes, Vance insurer fraud crackdown, Wisconsin governor race | `off_category` — pure political/insurance-business coverage |
| SNAP benefit rule/payment changes | `off_category` — benefits policy, not nutrition science |
| Health insurance shopping terms (Costco, Meritain, Devoted, UHC portal, open enrollment 2027) | `off_category` — insurance marketplace content |
| Menopause wellness binge, DC wellness resort, Rochester wellness dog, Shrewsbury/Purdue/CU Denver events, Army coaching, Amazon Prime Day wellness deals, Forbes wellness boom, Gilead×Calm | `off_category` — local/promotional/commerce/business-trend, no evidence angle |
| Stephen A. Smith / Lane Johnson mental health comments | `brand_safety` — celebrity-adjacent, no clear evidence angle |
| WHO global health landscape estimates | `other` — monitor (P5); global/aggregate scope, weak direct US-audience hook |
| Medscape "FDA recall problems raise liability questions" | `other` — trade-press/liability framing, low consumer audience fit |
| Ochsner AI trial screening, Pfizer AI patient matching, Mount Sinai EHR-to-EDC, Verana/Bitfount, Rovia infrastructure, IceCure expansion, UNC Rett gene therapy, UNLV women's health trials, NeuWire stroke device, Nature ALS Finland study, UCLA Neural Consult app, UNMC/Susquehanna research digests, Harvard cell-infection study | `weak_signal` — B2B/trade framing, too niche, or local/academic-digest with low general-audience pull |
| GLP-1 pipeline (six-month tirzepatide data, CBL-514 injection) | `other` — real Trends interest but no corroborating news article today; deferred for recheck (3 days) |

---

## 8. Integrity Flags (Consolidated)

- ⚠️ **Eye drop recall**: confirm FDA.gov enforcement notice directly before publishing — only one secondary outlet captured today.
- ⚠️ **T1D insulin trial**: early-phase/small-cohort result — do not frame as a cure; confirm trial phase and follow-up duration.
- ⚠️ **Microglia/Parkinson's study**: confirm whether finding is preclinical (animal model) vs. human data before drawing patient-relevant conclusions.
- ⚠️ **VCU/TikTok docs update**: correlation (watching content) ≠ causation (behavior change) — keep framing descriptive, not causal.
- ⚠️ **UC Davis AI device trial**: trial-stage only — not FDA-cleared or commercially available; avoid implying home-use readiness.

---

## 9. Run Notes

- Self-check unavailable (`site_url` not configured); competitor-list fallback (configs/competitor_list.yaml) used to inform SERP-gap framing.
- Google Trends pre-fetch treated as available and used as primary `search_velocity` input per injected block; no estimation fallback needed.
- ARPA-H SURPASS program is now a 3-run recurring theme — recommend either a fresh angle (funding/budget disclosure, patient enrollment numbers) or suppressing entirely until a material development occurs.
- GLP-1 pipeline items (CBL-514, extended tirzepatide data) added to `data/deferred_topics.yaml` with `recheck_on: 2026-10-11`, pending a dedicated news article beyond Trends-only signal.
- No candidates were rejected or sent to Monitor at Skill 02b this run — all four high-risk health topics cleared with Medium-confidence caps and specific verification notes carried into their briefs.
- Dashboard write and `run_history.yaml` update assumed per standard workflow (file-system actions not reproduced in this chat output).